What’s New in Multiple Myeloma? [Webchat]

2

Multiple myeloma, or Kahler’s disease, is a type of cancer that begins in plasma cells – white blood cells that produce antibodies. Plasma cells usually work in the body’s immune defense system and help produce antibodies. In cases of multiple myeloma, however, too many plasma cells build up in the bone marrow.

In a recent Facebook Live webchat, Jacob Laubach, MD, MPP, Clinical Director of the Jerome Lipper Multiple Myeloma Center, discussed the different ways that patients can be treated with multiple myeloma, as well as exciting avenues of treatment, such as combination therapy. In combination therapy, multiple different drugs are used at the same time to treat a patient’s cancer.

“The rationale behind [combination therapy] is that these agents that are employed in the treatment of the disease have distinct, different mechanisms of action and together, they can eliminate cancer cells more effectively,” Laubach says, “We like to think of it in terms of Army, Navy, Air Force, and Marines: each component of the regiment brings something to bear against the cancer.”

Laubach also discussed new developments in clinical trials for multiple myeloma and answered questions from the audience.

“Here at Dana-Farber,” he says, “Our mission is to care for patients, and at the same time, to move this field forward, so that in five years, outcomes are better for patients than they are now.”

View a video of the March 31 webchat below.

Comments Sort By Newest

2 thoughts on “What’s New in Multiple Myeloma? [Webchat]

  1. My mom died of Multiple Myeloma after battling the disease for about 5 years. At that time she had a tremendous craving for celery and they said that was.a.sign of it’s presence. If that’s true or not I am really not sure.

  2. Excellent speaker/teacher. I’m a 14 year survivor. This was helpful to me in terms of scope and the translation of medical concepts that apply to myeloma. Thank you.

  3. Excellent speaker/teacher. I’m a 14 year survivor. This was helpful to me in terms of scope and the translation of medical concepts that apply to myeloma. Thank you.

  4. My mom died of Multiple Myeloma after battling the disease for about 5 years. At that time she had a tremendous craving for celery and they said that was.a.sign of it’s presence. If that’s true or not I am really not sure.

Leave a Reply

Your email address will not be published. Required fields are marked *

Blue Captcha Image
Refresh

*

Make An Appointment

For adults: 877-442-9599

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
WATCH: Jacob Laubach, MD, MPP, discusses different #multiplemyeoloma treatments, including combination therapy:… https://t.co/Skdaqeqdcl
Dana-Farber @danafarber
Facing only months to live, Doron Broman came to Dana-Farber hoping for a miracle. Today, Broman is cancer-free:… https://t.co/Mj6jpuPh46
Dana-Farber @danafarber
Expanding access to #bloodcancer clinical trials is the mission of the Blood Cancer Research Partnership:… https://t.co/aGmG83xMSd

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.